Diabetic's Choice

03/31/2026

Physiologic Insulin Resensitization PIR at Diabetic’s Choice

03/31/2026

https://www.facebook.com/share/p/1CQzTXLgmp/?mibextid=wwXIfr

Main Menu

03/28/2026

03/27/2026

CKD doesn’t have to be a one-way road.
Chronic Kidney Disease can progress from early kidney damage to complete kidney failure, often leading to dialysis or even death if the root cause isn’t addressed.

At Diabetic’s Choice, PIR Therapy (Physiologic Insulin Resensitization) works to restore the body’s natural insulin signaling, improve cellular function, and target insulin resistance at the source.

• PIR stabilizes and reverses CKD up to Stage 5, 91% of the time
• Without PIR, 64% of CKD patients go on dialysis
• With PIR, 0% go on dialysis, 0% died

(Island Doctors Study & Caravaca-Fontán et al. study)

Restore Your Health • Regain Your Life

03/23/2026

Walk toward better health today with Diabetic’s Choice. Our mission is to empower those living with diabetes through compassionate care and innovative therapies that target the root cause of metabolic disorders, not just the symptoms. 💙

03/19/2026

The truth about Type 1 & Type 2 diabetes: ⚠️
Real people are dealing with real problems every day, and they deserve real results!

According to data from the Schull Institute:
📌 95% neuropathy improvement
📌 63% HbA1c reduction
📌 41% medication reduction

You do not have to keep settling for temporary fixes. Learn how you can get PIR at Diabetic’s Choice now and take the next step toward real results.

This is more than talk. This is hope backed by results. ✨
Restore Your Health. Regain Your Life 🙌

02/25/2026

Here at Diabetics Choice, through the use of physician-directed Physiologic Insulin Resensitization (PIR), the physician can administer insulin more precisely as a hormone rather than a drug—using insulin in a manner that biomimics normal physiology. PIR is designed to help physicians reduce their patients’ insulin resistance, which may help blood sugar more readily enter each cell and be converted into energy, treating both CKD patients and diabetics 🩺✨

Here are some stats from Schull Institute 📊
In Diabetes Patients, studies have shown ✅
95% Neuropathy improvement
67% HbA1c reduction
41% Medication reduction

In CKD stages 3a–5, studies have shown ✅
56% Stage Stabilization
34.85% Stage Improvement / Reversal

📩 Want to learn if PIR could be a fit for you? Send us a message or call today to schedule a consultation.

10/03/2024

Interested in an appointment?

Visit our website to fill out our "New Patient Forms" and a team member will call you to schedule a consult :)

NOTE: By providing your phone number when scheduling an appointment or submitting online forms, you consent to receive ​text message reminders about your appointments from Diabetic's Choice. This service is powered by GrowPractice.